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Medication errors (MEs) in children are frequent and associated
with increased risk of harm [1,2]. Incident reporting of errors is
considered a key element in strategies to reduce MEs [3]. Tra-
ditionally, analyses of ME reports involve narrative descriptions
and frequency counts which may cause important errors to be
overlooked or may entail an element of subjectivism [2,4]. A
formal approach to analysis of ME reports could involve dis-
proportionality principles used in pharmacovigilance, for exam-
ple the proportional reporting ratio (PRR) [5]. In large
databases, PRRs may help identify potential safety targets
which would go unnoticed when using frequency counts [6].
We aimed to explore the utility of disproportionality analy-
sis of medication errors involving hospitalized children.
Method
A retrospective analysis of MEs involving hospitalized children
reported to the national mandatory incident reporting system, the
Danish Patient Safety Database, was conducted. ME reports were
submitted from January 2010 to December 2014 and included both
near misses, that is errors intercepted before reaching the patients
and errors reaching the patients, involving inpatients aged
<18 years in different hospital settings. Prior to the analysis, MEs
were categorized according to ME type based on a modified ver-
sion of the National Coordinating Council for Medication Error
Reporting and Prevention (NCC MERP) taxonomy of MEs and
the medication involved (WHO’s Anatomical Therapeutic Chemical
(ATC) classification system 5th level) [7,8].
The calculation of PRRs is a hypothesis-generating method origi-
nally proposed by Evans et al. [6]. This method is primarily used
in pharmacovigilance to describe the association between medication
use and resulting adverse drug reactions. For a given large set of
reports, the method calculates the number of expected reports for a
particular combination of a medication and an event, given the
overall observed frequency of reports for this medication and for
this event in the entire dataset. The PPR is then the ratio between
the number of observed and expected reports. As a theoretical
example, we can calculate the association of paracetamol and wrong
dose errors expressed as PRR (table S1). Compared to other reports
of all other medications involving dosing errors, the PRR of parac-
etamol-‘wrong dose’ is 1.5, indicating an increased prevalence of
reporting involving this medication–event pair compared to all other
medications.
We calculated PRRs for all medication–event pairs using ME type
as the event. A signal was arbitrarily defined as a PRR ≥2, a number
of cases ≥3 and a p-value <0.05 according to Evans et al. (2001) [6].
The size of the PRR reflects the strength of the signal. PRR ≥2 was
chosen to highlight medication–event pairs with a higher reporting rate
than expected. The null (or expected) value for PRR is one, that is the
value when there is no association.
p-Values were calculated by exact Poisson distributions, using the
expected count as the Poisson parameter, k. We ranked the signals
according to the excess number of reports, that is the numerical differ-
ence between the observed and expected number of reports.
Results
In total, 43 signals were identified from 2071 reported MEs
involving 620 different medication–event pairs (table 1). High
PRR values were observed for terbutaline-wrong dosage form
(PRR = 36.6), metoclopramide-wrong patient (PRR = 20.4),
pantoprazole-wrong patient (PRR = 18.7) and sulphamethoxa-
zole and trimethoprim-wrong duration (PRR = 18.7). Top
ranking pairs (excess ≥6) included gentamicin-wrong time (ex-
cess = 19.3), acetylcysteine-wrong rate (excess = 8.1) and
amoxicillin-wrong medication (excess = 6.9).
Discussion
Several medication–event pairs were identified through dispro-
portionality analysis of ME reports involving hospitalized chil-
dren submitted to a large national reporting system. These
pairs were likely to have been unrecognized by traditional
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methods involving frequency counts and review of narrative
descriptions [2].
To our knowledge, no study has previously explored the use of
disproportionality analysis of ME reports in children or hospital
settings. However, PRRs have been used to identify medication–
event pairs involving ME reports from nursing homes [10].
The ME reports have previously been described using fre-
quency counts and narrative descriptions [2]. Using frequency
Table 1.
Analyses of proportional reporting ratio (PRR) for 2071 reports of medication errors involving hospitalized children. Medication–event combina-
tions were ranked according to the excess, that is, the numerical difference between observed and expected reports.
Medication Event
Observed number
of reports
Expected number
of reports PRR p-value
Excess number
of reports
Gentamicin (J01GB03) Wrong time 29 9.7 3.0 <0.0001 19.3
Acetylcysteine (V03AB23) Wrong rate 9 0.9 9.8 <0.0001 8.1
Amoxicillin (J01CA04) Wrong medication 9 2.1 4.3 <0.0001 6.9
Caffeine (N06BC01) Dose omission 9 3.1 2.9 0.0014 5.9
Solutions for parenteral
nutrition combinations (B05BA10)
Wrong medication 7 1.5 4.6 0.0002 5.5
Gentamicin (J01GB03) Wrong duration 8 2.7 3.0 0.0017 5.3
Ceftriaxone (J01DD04) Wrong medication 7 2.2 3.2 0.0021 4.8
Metoclopramide (A03FA01) Wrong patient 5 0.2 20.4 <0.0001 4.8
Sodium bicarbonate (B05XA02) Wrong medication 6 1.5 4.0 0.0010 4.5
Dexamethasone (H02AB02) Wrong time 6 1.6 3.8 0.0012 4.4
Electrolytes with carbohydrates
(B05BB02)
Wrong medication 6 1.6 3.7 0.0015 4.4
Electrolytes (B05BB01) Wrong medication 7 2.7 2.6 0.0063 4.3
Pantoprazole (A02BC02) Wrong patient 4 0.2 18.7 <0.00701 3.8
Sulphamethoxazole and
trimethoprim (J01EE01)
Wrong duration 4 0.2 18.7 <0.0001 3.8
Vancomycin (J01XA01) Wrong route of
administration
4 0.3 14.8 <0.0001 3.7
Diazepam (N05BA01) Dose omission 5 1.4 3.7 0.0028 3.6
Sodium phosphate (A06AG01) Wrong duration 4 0.6 6.8 0.0004 3.4
Sodium phosphate (A06AG01) Wrong patient 4 0.7 5.9 0.0007 3.3
Diclofenac (M01AB05) Wrong dosage form 4 0.7 5.5 0.0009 3.3
Methotrexate (L01BA01) Wrong time 5 1.9 2.7 0.0120 3.1
Terbutaline (R03AC03) Wrong dosage form 3 0.1 36.6 <0.0001 2.9
Multivitamins and trace
elements (A11AA04)
Dose omission 4 1.1 3.6 0.0057 2.9
Cytarabine (L01BC01) Wrong time 4 1.2 3.4 0.0071 2.8
Ibuprofen (M01AE01) Wrong patient 4 1.2 3.3 0.0076 2.8
Furosemide (C03CA01) Unauthorized
medication
3 0.2 15.2 <0.0001 2.8
Morphine (N02AA01) Wrong rate 5 2.2 2.2 0.0267 2.8
Clonidine (N02CX02) Wrong route of
administration
3 0.2 12.4 0.0001 2.8
Hepatitis B immunoglobulin
(J06BB04)
Wrong time 3 0.3 10.2 0.0002 2.7
Fentanyl (N01AH01) Wrong rate 3 0.3 8.9 0.0004 2.7
Paracetamol (N02BE01) Unauthorized
medication
4 1.4 2.9 0.0128 2.6
Calcium levofolinate (V03AF04) Wrong time 3 0.4 7.7 0.0007 2.6
Piperacillin and enzyme
inhibitor (J01CR05)
Wrong patient 3 0.4 7.0 0.0010 2.6
Voriconazole (J02AC03) Dose omission 3 0.5 6.1 0.0017 2.5
Lomustine (L01AD02) Wrong medication 3 0.6 5.1 0.0030 2.4
Sodium bicarbonate (B05XA02) Dose omission 4 1.6 2.5 0.0241 2.4
Potassium chloride (B05XA01) Wrong medication 4 1.6 2.5 0.0254 2.4
Electrolytes with
carbohydrates (B05BB02)
Dose omission 4 1.7 2.3 0.0316 2.3
Cefuroxime (J01DC02) Wrong duration 4 1.8 2.3 0.0342 2.2
Meropenem (J01DH02) Wrong patient 3 0.8 3.8 0.0089 2.2
Fluticasone (R03BA05) Wrong medication 3 0.8 3.7 0.0097 2.2
Calcium folinate (V03AF03) Wrong time 3 0.9 3.4 0.0126 2.1
Heparin (B01AB01) Wrong medication 3 1.2 2.6 0.0308 1.8
Prednisolone (H02AB06) Wrong medication 3 1.3 2.3 0.0413 1.7
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counts, medications including gentamicin, acetylcysteine, mor-
phine, cefuroxime, diclofenac, ibuprofen and carbohydrates
were identified to be involved in the majority of reports. How-
ever, the large dataset involving 620 different medication–
event pairs prevented us from noticing most of the medica-
tion–event pairs identified using PRRs.
The disproportionality analysis used in this study is almost
exclusively used in pharmacovigilance. Within safety moni-
toring of medications, the general principle of the method
was to address medication drug reactions associated with
consumption of certain medicines, which could ultimately
lead to withdrawal of a medication from the market [6]. In
relation to incident reporting, disproportionality analysis
should be seen as a supplementary tool to help identify
events in large databases, which can be targeted through
quality improvement [10]. For example, the large number of
excess reports on gentamicin and wrong time of administra-
tion in our study may suggest that a clinical/organizational
follow-up is warranted to reduce this number. Possibly, the
organization concerning intravenous medication administra-
tion is too vulnerable towards distractions in Danish paedi-
atric hospitals. Further, signals concerned with wrong
infusion rate of acetylcysteine and prescribing of a wrong
drug (amoxicillin instead of phenoxymethylpenicillin to treat
pneumonia) indicate the need for improved communication
and training of frontline staff about existing medication
guidelines to ensure appropriate medication prescribing and
administration. In national incident reporting systems, PRRs
may prompt further investigation of potential safety targets
and facilitate the development of strategies to reduce MEs.
Factors to determine which signals to investigate further
involve the strengths of the signal, the potential or actual
harm of the medication error events and the potential to pre-
vent the errors from occurring [6].
It should be noted that PRRs involving ME reports, like
those PRRs involved in traditional pharmacovigilance, should
not be interpreted as measures of association, that is, some-
thing similar to the relative risk or incidence rate ratio. It
rather reflects the extent to which these medication–event
combinations are striking, strange or conspicuous to the clini-
cians involved in reporting [6].
A strength of the disproportionality analysis is its simplicity
and efficiency in processing, even for large datasets. In addi-
tion, the calculated PRR is robust towards general under-
reporting for the given medication and general under-reporting
for the given event [6]. However, our ranking of the medica-
tion–event combination may to some extent be affected by
general under-reporting. If there were a generally low report-
ing rate for a given medication or an event, we would observe
fewer reports involving these. While the PRR would be unaf-
fected, these medication–event combinations would be unli-
kely to generate high values of the ‘excess’ that we used for
ranking. On the contrary, healthcare professionals may tend to
report certain types of events such as ten times overdosing
errors or potential or actual serious MEs causing reporting
bias. This is supported by reports from another spontaneous
reporting scheme [11].
Conclusion
Medication error reports among hospitalized children can
meaningfully be subjected to pharmacovigilance-type analyses,
such as the PRR, which may provide guidance to identify
problems in the handling of medication.
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